A framework for safe obstetrical practices.

Int J Gynaecol Obstet

University Medical Centre, Utrecht, The Netherlands.

Published: February 2021

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijgo.13539DOI Listing

Publication Analysis

Top Keywords

framework safe
4
safe obstetrical
4
obstetrical practices
4
framework
1
obstetrical
1
practices
1

Similar Publications

Evidence of organizational support in hospitals in the context of the COVID-19 pandemic: scoping review.

Rev Gaucha Enferm

January 2025

Universidade de São Paulo, Escola de Enfermagem, Programa de Pós-Graduação em Gerenciamento em Enfermagem, São Paulo, São Paulo, Brasil.

Objective: To map evidence of organizational support for healthcare professionals who worked in hospitals during the pandemic.

Method: This is a scoping review, based on the framework established by Joanna Briggs Institute and the PRISMA-ScR protocol, registered in the Open Science Framework, under DOI: 10.17605/OSF.

View Article and Find Full Text PDF

Background: Agile methodology (AM) is an innovative, active, project-based learning method. The scrum is a popular agile framework widely used in project management and education. This study evaluates the opinions on agile adaptation in nursing curricula among nursing students to identify how AM can be applied in higher education to facilitate learning.

View Article and Find Full Text PDF

This paper explores the integration of haptic gloves and virtual reality (VR) environments to enhance industrial training and operational efficiency within the framework of Industry 4.0 and Industry 5.0.

View Article and Find Full Text PDF

Scoping review of initiation criteria for inhaled nitric oxide in preterm infants (born <34 weeks) after 7 days of age.

BMJ Open

December 2024

Research and Development Center for New Medical Frontiers, Department of Advanced Medicine, Division of Neonatal Intensive Care Medicine, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.

Objectives: Inhaled nitric oxide (iNO) is a known treatment for pulmonary hypertension (PH) associated with bronchopulmonary dysplasia in preterm infants after 7 days of age (postacute phase). However, a consensus regarding the optimal criteria for initiating iNO therapy in this population in the postacute phase is currently lacking. This study, therefore, aimed to identify the criteria for initiating iNO therapy, alongside the associated clinical and echocardiographic findings, in this population.

View Article and Find Full Text PDF

CRISPR-Cas9 Targeting PCSK9: A Promising Therapeutic Approach for Atherosclerosis.

J Cardiovasc Transl Res

January 2025

Department of Cardiology, Affiliated Hospital of Southwest Medical University, No.1 Section 1, Xiang Lin Road, Longmatan District, Luzhou, Sichuan, 646000, China.

CRISPR-Cas9 gene editing technology, as an innovative biomedical tool, holds significant potential in the prevention and treatment of atherosclerosis. By precisely editing key genes such as PCSK9, CRISPR-Cas9 offers the possibility of long-term regulation of low-density lipoprotein cholesterol (LDL-C), which may reduce the risk of cardiovascular diseases. Early clinical studies of gene editing therapies like VERVE-101 have yielded encouraging results, highlighting both the feasibility and potential efficacy of this technology.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!